STANDARD BIOTOOLS INC. 8-K

What Happened

• On January 8, 2026, Standard BioTools Inc. (LAB) issued a press release (attached as Exhibit 99.1) disclosing certain preliminary financial results for the three months and fiscal year ended December 31, 2025.
• The reported figures are preliminary and unaudited, based on current expectations, and may be adjusted as a result of completion of annual audit procedures and final closing processes.

Key Details

• Date of report and press release: January 8, 2026.
• Period covered: three months and fiscal year ended December 31, 2025.
• Status of results: preliminary, unaudited, subject to completion of financial closing and audit procedures.
• Filing status: information furnished (Exhibit 99.1), not “filed” under Section 18 and not automatically incorporated by reference into other registration statements.

Why It Matters

• This is an early update on LAB’s earnings and financial condition for Q4/FY2025; preliminary results can move investor expectations for revenue, profitability and guidance.
• Because the numbers are unaudited and may change, investors should treat this as provisional information and await the final audited results (typically in the Form 10-K or a subsequent 8-K) before making decisions.
• Look for the company’s subsequent filings or investor release for final audited figures and management commentary to assess trends in revenue, margins, and cash flow.